PPARA and type 2 diabetes mellitus: The current longitudinal interventional study revealed that the fenofibrate nano-eyedrops (FenoNano) prevent glial dysfunction via the phosphorylation of PPAR-α and improve the retinal blood flow dysregulation and impaired neurovascular coupling in the retina in type 2 diabetic mice.